Aims and Scope of Cancer
Cancer is a biweekly peer-reviewed scientific journal covering oncology. The journal was established in 1948. It is an official journal of the American Cancer Society and is published by Wiley-Blackwell on behalf of the society. The first editor-in-chief was Fred W. Stewart, who held that position until 1961. The current editor-in-chief is Fadlo R. Khuri. Cancer Cytopathology was published as a section from 1997 until 2008 when it was split into a separate journal. Less
Key Metrics
CiteScore 

11.2
Eigenfactor 

0.05 - 0.1
H-Index 

327
Impact Factor 

5 - 10
Scite Index 

0.87 5-Year SI

SJR 

Q1Oncology

SNIP 

2.18
Recommended pre-submission checks
Powered by 

Topics Covered on Cancer
Cancer Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 1947 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Cancer
Selinexor in combination with azacitidine or ruxolitinib in myelodysplastic/myeloproliferative neoplasm overlap syndromes: A multicenter prospective study.
- 1 Jul 2026
- Cancer
Clinical trial enrollment processes and strategies to enhance clinical trial participation at rural National Cancer Institute Community Oncology Research Program sites.
- 1 Jul 2026
- Cancer
Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O6-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 study.
- 1 Jul 2026
- Cancer
Proliferative ecotype determines lethal prognosis andtherapeutic benefit in urothelial carcinoma.
- 1 Jul 2026
- Cancer
Correction to "Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025".
- 1 Jul 2026
- Cancer
"Protected time" for clinical investigators in medical oncology: The persistent gap between expectation and reality.
- 1 Jul 2026
- Cancer
Selinexor in combination with azacitidine or ruxolitinib in myelodysplastic/myeloproliferative neoplasm overlap syndromes: A multicenter prospective study.
- 1 Jul 2026
- Cancer
Clinical trial enrollment processes and strategies to enhance clinical trial participation at rural National Cancer Institute Community Oncology Research Program sites.
- 1 Jul 2026
- Cancer
Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O6-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 study.
- 1 Jul 2026
- Cancer
Proliferative ecotype determines lethal prognosis andtherapeutic benefit in urothelial carcinoma.
- 1 Jul 2026
- Cancer
Correction to "Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025".
- 1 Jul 2026
- Cancer
"Protected time" for clinical investigators in medical oncology: The persistent gap between expectation and reality.
- 1 Jul 2026
- Cancer
FAQs on Cancer
How long has Cancer been actively publishing? 
What is the publishing frequency of Cancer? 
How many articles did Cancer publish last year? 
What is the eISSN & pISSN for Cancer? 
What is Citescore for Cancer? 
What is the H Index for Cancer ? 
What is SNIP score for Cancer? 
What is the SJR for Cancer? 
Who is the publisher of Cancer? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary